Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 4Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 267Prostatic Neoplasms 144Neoplasms 139Lung Neoplasms 84Colorectal Neoplasms 61Motor Activity 55Uterine Cervical Neoplasms 44Carcinoma, Non-Small-Cell Lung 43Pancreatic Neoplasms 35Head and Neck Neoplasms 34Colonic Neoplasms 34Ovarian Neoplasms 33Brain Neoplasms 32Carcinoma, Hepatocellular 27Neoplasm Metastasis 26Rectal Neoplasms 24Stomach Neoplasms 22Melanoma 19Hematologic Neoplasms 19Endometrial Neoplasms 19Liver Neoplasms 18Anxiety Disorders 18Kidney Neoplasms 16Glioma 16Squamous Cell Carcinoma of Head and Neck 15Papillomavirus Infections 15Fatigue 15Esophageal Neoplasms 15Obesity 14Multiple Myeloma 14

Interventions

Methotrexate 1Leucovorin 1Dactinomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × Gestational Trophoblastic Disease × Clear all
NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Peking Union Medical College Hospital

Phase NA Active not recruiting
228 enrolled
Gynecologic

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡